Download PDF
Klin Monbl Augenheilkd 2020; 237(11): 1306-1311
DOI: 10.1055/a-1291-9383
Übersicht

Ophthalmological Management of Patients with Pituitary Adenomas

Article in several languages: English | deutsch
Sebastian Küchlin 
Eye Center, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Germany
,
Wolf Alexander Lagrèze
Eye Center, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Germany
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Pituitary tumours are a common cause of functional impairment and degeneration of the anterior visual pathway. Depending on localization and size, they clinically manifest as initially reversible visual field defects. As part of interdisciplinary tumour management, ophthalmologic examinations are of particular importance concerning diagnostics, indication for tumour resection and documentation of functional surgical results. Based on the relationship between clinical dysfunction and manifest atrophy, together with the patientʼs age and the duration of symptoms, the ophthalmologist can provide insights into the postoperative visual prognosis. Under good conditions, surgical tumour resection often results in significant improvements to visual fields and acuity. Long-term ophthalmological controls are required in cases of persistent visual loss, radiotherapy or tumour remnants abutting the visual pathway.

Key words

neuro-ophthalmology - pituitary tumour - perimetry - tumour management


Publication History

Received: 28 September 2020

Accepted: 15 October 2020

Article published online:
17 November 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References/Literatur

  • 1 Mehta GU, Lonser RR. Management of hormone-secreting pituitary adenomas. Neuro Oncol 2017; 19: 762-773
    PubMedGoogle Scholar
  • 2 Vosteen K-H. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Unfallchirurgie 1992; 18: 55-56
    CrossrefPubMedGoogle Scholar
  • 3 Molitch ME. Diagnosis and Treatment of Pituitary Adenomas: A Review. JAMA 2017; 317: 516-524
    Google Scholar
  • 4 Fraser CL, Biousse V, Newman NJ. Visual Outcomes After Treatment of Pituitary Adenomas. Neurosurg Clin N Am 2012; 23: 607-619
    CrossrefPubMedGoogle Scholar
  • 5 Molitch ME. Pituitary incidentalomas. Best Pract Res Clin Endocrinol Metab 2009; 23: 667-675
    CrossrefPubMedGoogle Scholar
  • 6 Melmed S, Casanueva FF, Hoffman AR. et al. Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2011; 96: 273-288
    CrossrefPubMedGoogle Scholar
  • 7 Chanson P, Raverot G, Castinetti F. et al. Management of clinically non-functioning pituitary adenoma. Ann Endocrinol (Paris) 2015; 76: 239-247
    CrossrefPubMedGoogle Scholar
  • 8 Wilson P, Falconer MA. Patterns of visual failure with pituitary tumours. Clinical and radiological correlations. Br J Ophthalmol 1968; 52: 94-110
    CrossrefPubMedGoogle Scholar
  • 9 Thomas R, Shenoy K, Seshadri MS. et al. Visual field defects in non-functioning pituitary adenomas. Indian J Ophthalmol 2002; 50: 127-130
    PubMedGoogle Scholar
  • 10 Ogra S, Nichols AD, Stylli S. et al. Visual acuity and pattern of visual field loss at presentation in pituitary adenoma. J Clin Neurosci 2014; 21: 735-740
    CrossrefPubMedGoogle Scholar
  • 11 Aghi MK, Chen CC, Fleseriu M. et al. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Management of Patients With Nonfunctioning Pituitary Adenomas: Executive Summary. Neurosurgery 2016; 79: 521-523
    CrossrefPubMedGoogle Scholar
  • 12 Abouaf L, Vighetto A, Lebas M. Neuro-ophthalmologic exploration in non-functioning pituitary adenoma. Ann Endocrinol (Paris) 2015; 76: 210-219
    CrossrefPubMedGoogle Scholar
  • 13 Monteiro MLR, Zambon BK, Cunha LP. Predictive factors for the development of visual loss in patients with pituitary macroadenomas and for visual recovery after optic pathway decompression. Can J Ophthalmol 2010; 45: 404-408
    CrossrefPubMedGoogle Scholar
  • 14 Qiao N, Ye Z, Shou X. et al. Discrepancy between structural and functional visual recovery in patients after trans-sphenoidal pituitary adenoma resection. Clin Neurol Neurosurg 2016; 151: 9-17
    CrossrefPubMedGoogle Scholar
  • 15 Esposito D, Olsson DS, Ragnarsson O. et al. Non-functioning pituitary adenomas: indications for pituitary surgery and post-surgical management. Pituitary 2019; 22: 422-434
    CrossrefPubMedGoogle Scholar
  • 16 Dekkers OM, de Keizer RJW, Roelfsema F. et al. Progressive improvement of impaired visual acuity during the first year after transsphenoidal surgery for non-functioning pituitary macroadenoma. Pituitary 2007; 10: 61-65
    CrossrefPubMedGoogle Scholar
  • 17 Kerrison JB, Lynn MJ, Baer CA. et al. Stages of improvement in visual fields after pituitary tumor resection. Am J Ophthalmol 2000; 130: 813-820
    CrossrefPubMedGoogle Scholar
  • 18 Danesh-Meyer HV, Wong A, Papchenko T. et al. Optical coherence tomography predicts visual outcome for pituitary tumors. J Clin Neurosci 2015; 22: 1098-1104
    CrossrefPubMedGoogle Scholar
  • 19 Lee J, Kim SW, Kim DW. et al. Predictive model for recovery of visual field after surgery of pituitary adenoma. J Neurooncol 2016; 130: 155-164
    CrossrefPubMedGoogle Scholar
  • 20 Moon CH, Hwang SC, Ohn YH. et al. The Time Course of Visual Field Recovery and Changes of Retinal Ganglion Cells after Optic Chiasmal Decompression. Invest Ophthalmol Vis Sci 2011; 52: 7966
    CrossrefPubMedGoogle Scholar
  • 21 Gnanalingham KK, Bhattacharjee S, Pennington R. et al. The time course of visual field recovery following transphenoidal surgery for pituitary adenomas: predictive factors for a good outcome. J Neurol Neurosurg Psychiatry 2005; 76: 415-419
    CrossrefPubMedGoogle Scholar
  • 22 Guy J, Mancuso A, Beck R. et al. Radiation-induced optic neuropathy: a magnetic resonance imaging study. J Neurosurg 1991; 74: 426-432
    CrossrefPubMedGoogle Scholar
  • 23 Zhao Z, Lan Y, Bai S. et al. Late-onset radiation-induced optic neuropathy after radiotherapy for nasopharyngeal carcinoma. J Clin Neurosci 2013; 20: 702-706
    CrossrefPubMedGoogle Scholar
  • 24 Murad MH, Fernández-Balsells MM, Barwise A. et al. Outcomes of surgical treatment for nonfunctioning pituitary adenomas: a systematic review and meta-analysis. Clin Endocrinol (Oxf) 2010; 73: 777-791
    CrossrefPubMedGoogle Scholar
  • 25 Trautmann JC, Laws ER. Visual Status after Transsphenoidal Surgery at the Mayo Clinic, 1971–1982. Am J Ophthalmol 1983; 96: 200-208
    CrossrefPubMedGoogle Scholar
  • 26 Yu FF, Chen LL, Su YH. et al. Factors influencing improvement of visual field after trans-sphenoidal resection of pituitary macroadenomas: a retrospective cohort study. Int J Ophthalmol 2015; 8: 1224-1228
    PubMedGoogle Scholar
  • 27 Anik I, Anik Y, Koc K. et al. Evaluation of early visual recovery in pituitary macroadenomas after endoscopic endonasal transphenoidal surgery: Quantitative assessment with diffusion tensor imaging (DTI). Acta Neurochir (Wien) 2011; 153: 831-842
    CrossrefPubMedGoogle Scholar
  • 28 Lee DK, Sung MS, Park SW. Factors Influencing Visual Field Recovery after Transsphenoidal Resection of a Pituitary Adenoma. Korean J Ophthalmol 2018; 32: 488
    CrossrefPubMedGoogle Scholar
  • 29 Luomaranta T, Raappana A, Saarela V. et al. Factors Affecting the Visual Outcome of Pituitary Adenoma Patients Treated with Endoscopic Transsphenoidal Surgery. World Neurosurg 2017; 105: 422-431
    CrossrefPubMedGoogle Scholar
  • 30 Muskens IS, Zamanipoor Najafabadi AH, Briceno V. et al. Visual outcomes after endoscopic endonasal pituitary adenoma resection: a systematic review and meta-analysis. Pituitary 2017; 20: 539-552
    CrossrefPubMedGoogle Scholar
  • 31 Zaidi HA, Cote DJ, Burke WT. et al. Time Course of Symptomatic Recovery After Endoscopic Transsphenoidal Surgery for Pituitary Adenoma Apoplexy in the Modern Era. World Neurosurg 2016; 96: 434-439
    CrossrefPubMedGoogle Scholar
  • 32 Dhasmana R, Nagpal RC, Sharma R. et al. Visual Fields at Presentation and after Trans-sphenoidal Resection of Pituitary Adenomas. J Ophthalmic Vis Res 2011; 6: 187-191
    PubMedGoogle Scholar
  • 33 Schmalisch K, Milian M, Schimitzek T. et al. Predictors for visual dysfunction in nonfunctioning pituitary adenomas – implications for neurosurgical management. Clin Endocrinol (Oxf) 2012; 77: 728-734
    CrossrefPubMedGoogle Scholar
  • 34 Ikeda H, Yoshimoto T. Visual disturbances in patients with pituitary adenoma. Acta Neurol Scand 1995; 92: 157-160
    CrossrefPubMedGoogle Scholar
  • 35 Thotakura AK, Patibandla MR, Panigrahi MK. et al. Predictors of visual outcome with transsphenoidal excision of pituitary adenomas having suprasellar extension: a prospective series of 100 cases and brief review of the literature. Asian J Neurosurg 2017; 12: 1
    Article in Thieme ConnectPubMedGoogle Scholar
  • 36 Bedrosian JC, McCoul ED, Raithatha R. et al. A prospective study of postoperative symptoms in sinonasal quality-of-life following endoscopic skull-base surgery: dissociations based on specific symptoms. Int Forum Allergy Rhinol 2013; 3: 664-669
    CrossrefPubMedGoogle Scholar
  • 37 Sahyouni R, Goshtasbi K, Choi E. et al. Vision Outcomes in Early versus Late Surgical Intervention of Pituitary Apoplexy: Meta-Analysis. World Neurosurg 2019; 127: 52-57
    Google Scholar
  • 38 Sim FJ, Zhao C, Penderis J. et al. The Age-Related Decrease in CNS Remyelination Efficiency Is Attributable to an Impairment of Both Oligodendrocyte Progenitor Recruitment and Differentiation. J Neurosci 2002; 22: 2451-2459
    CrossrefPubMedGoogle Scholar
  • 39 Rajasekaran S, Vanderpump M, Baldeweg S. et al. UK guidelines for the management of pituitary apoplexy. Clin Endocrinol (Oxf) 2011; 74: 9-20
    CrossrefPubMedGoogle Scholar
  • 40 Yoneoka Y, Hatase T, Watanabe N. et al. Early morphological recovery of the optic chiasm is associated with excellent visual outcome in patients with compressive chiasmal syndrome caused by pituitary tumors. Neurol Res 2015; 37: 1-8
    CrossrefPubMedGoogle Scholar
  • 41 Jacob M, Raverot G, Jouanneau E. et al. Predicting Visual Outcome After Treatment of Pituitary Adenomas With Optical Coherence Tomography. Am J Ophthalmol 2009; 147: 64-70.e2
    CrossrefPubMedGoogle Scholar
  • 42 Cohen AR, Cooper PR, Kupersmith MJ. et al. Visual Recovery after Transsphenoidal Removal of Pituitary Adenomas. Neurosurgery 1985; 17: 446-452
    CrossrefPubMedGoogle Scholar
  • 43 Barzaghi LR, Medone M, Losa M. et al. Prognostic factors of visual field improvement after trans-sphenoidal approach for pituitary macroadenomas: review of the literature and analysis by quantitative method. Neurosurg Rev 2012; 35: 369-379
    CrossrefPubMedGoogle Scholar
  • 44 Lee S, Kim SJ, Yu YS. et al. Prognostic factors for visual recovery after transsphenoidal pituitary adenectomy. Br J Neurosurg 2013; 27: 425-429
    CrossrefPubMedGoogle Scholar
  • 45 Ammirati M, Wei L, Ciric I. Short-term outcome of endoscopic versus microscopic pituitary adenoma surgery: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 2013; 84: 843-849
    CrossrefPubMedGoogle Scholar